Prevention of cervical cancer - The National Screening program in Norway
Prevence rakoviny děložního hrdla - Národní screeningový program v Norsku
diplomová práce (OBHÁJENO)
Zobrazit/ otevřít
Trvalý odkaz
http://hdl.handle.net/20.500.11956/14175Identifikátory
SIS: 13624
Kolekce
- Kvalifikační práce [3193]
Autor
Vedoucí práce
Fakulta / součást
3. lékařská fakulta
Obor
-
Katedra / ústav / klinika
Ústav pro péči o matku a dítě v Praze Podolí
Datum obhajoby
1. 4. 2008
Nakladatel
Univerzita Karlova, 3. lékařská fakultaJazyk
Angličtina
Známka
Výborně
Cervical cancer is the second most common form of cancer in women in the developing world, but the incidence is generally lower in the Western part of the world. In Europe approximately 52 000 women are diagnosed each year, of which 27 000 die of the disease. Every day a woman gets diagnosed with cervical cancer, while almost ten women receives the diagnosis of severe pre malignant state. The disease is the second most common cause of death due to cancer among women globally and lead to ca. 190 000 deaths annually. In Norway a national mass examination program against cervical cancer has been in practice since 1995. The aim is to reduce prevalence and mortality while at the same time promote rational testing procedures.